https://www.selleckchem.com/pr....oducts/dabrafenib-gs
50, 0.43, and 0.50, respectively. CSUC was higher in 12 patients who relapsed within 1year than in 29 patients who remained in clinical remission (2.83±1.95 vs 0.72±1.00, P0.01). Receiver operator characteristic curve analysis showed that CSUC ≥1 was a predictor of relapse (area under the curve of 0.82, sensitivity of 83.3%, specificity of 58.6%) and maybe superior to fecal biomarkers. In the univariate analysis, patients with CSUC of 0 had a lower relapse rate than those with CSUC of ≧1 (P=0.03, log-rank test). After
إعجاب
علق
شارك
